Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China flag China · Delayed Price · Currency is CNY
6.27
+0.14 (2.28%)
Sep 29, 2026, 10:05 AM CST

Shanghai Kinetic Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
759.53946.1962.74933.631,1461,258
Other Revenue
17.6816.9721.7822.6319.7710.44
777.21963.06984.52956.261,1661,269
Revenue Growth
-26.31%-2.18%2.96%-17.99%-8.08%19.50%
Cost of Revenue
327.5487.17505.43466.09425.97490.52
Gross Profit
449.71475.9479.09490.17740.07778.06
Selling, General & Admin
303.06352.18348.72353.05436.31406.76
Research & Development
48.8951.4143.359.3461.469.77
Other Operating Expenses
9.16.755.566.9710.449.67
Operating Expenses
364.16415.96399.97410.4527.81497.7
Operating Income
85.5559.9379.1279.78212.26280.36
Interest Expense
-3.17-7.47-6.67-6.56-14.12-22.66
Interest & Investment Income
93.9431.158.1746.4716.5627.8
Currency Exchange Gain (Loss)
-0.37-1.66-0.530.48-2.331.12
Other Non Operating Income (Expenses)
-2.92-3.27-3.37-4.26-4.17-2.76
EBT Excluding Unusual Items
173.0378.6876.73115.9208.2283.86
Impairment of Goodwill
-----197.99-149.26
Gain (Loss) on Sale of Investments
40.4356.75-195.071.19-28.935.25
Gain (Loss) on Sale of Assets
0.80.26-0.1-0.370.211.6
Asset Writedown
-0.83-0.38-2.91-0.58-2.01-0.14
Other Unusual Items
19.7510.1710.9917.4418.2344.93
Pretax Income
233.18145.48-110.37133.57-2.26216.31
Income Tax Expense
15.9313.86-14.156.9821.6941.31
Earnings From Continuing Operations
217.25131.62-96.22126.6-23.95175
Minority Interest in Earnings
7.763.27-9.35-14.062.67-13.22
Net Income
225.01134.89-105.57112.54-21.28161.78
Net Income to Common
225.01134.89-105.57112.54-21.28161.78
Net Income Growth
------
Shares Outstanding (Basic)
717717717717719722
Shares Outstanding (Diluted)
717717717717719722
Shares Change
-0.04%-0.01%0.05%-0.31%-0.40%-0.16%
EPS (Basic)
0.310.19-0.150.16-0.030.22
EPS (Diluted)
0.310.19-0.150.16-0.030.22
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
202.08122.8874.91220.47195.3328.94
Free Cash Flow Per Share
0.280.170.100.310.270.46
Dividend Per Share
0.1000.100-0.060-0.050
Dividend Growth
-----0%
Gross Margin
57.86%49.41%48.66%51.26%63.47%61.33%
Operating Margin
11.01%6.22%8.04%8.34%18.20%22.10%
Profit Margin
28.95%14.01%-10.72%11.77%-1.82%12.75%
Free Cash Flow Margin
26.00%12.76%7.61%23.06%16.75%25.93%
EBITDA
124.63109.31148.63145.6273.16337.18
EBITDA Margin
16.04%11.35%15.10%15.23%23.43%26.58%
D&A For EBITDA
39.0849.3869.5265.8360.956.81
EBIT
85.5559.9379.1279.78212.26280.36
EBIT Margin
11.01%6.22%8.04%8.34%18.20%22.10%
Effective Tax Rate
6.83%9.53%-5.22%-19.10%
Revenue as Reported
777.21963.06984.52956.261,1661,269